Ad
related to: what happened to mylanta liquid medicine
Search results
Results From The WOW.Com Content Network
In November 2010, Mylanta was voluntarily recalled [2] due to what is described as some labelling concerns. According to sources within the company at that time, these concerns stemmed from the fact that small traces of alcohol were found in the flavoring agents of the liquid version of the antacid which was not disclosed on the labelling itself, and that the problem would be rectified "shortly".
Johnson & Johnson-Merck Consumer Pharmaceuticals Co. recalled 12 million bottles of Mylanta and thousands of packages of AlternaGel because flavoring used in the products contains a small amount ...
The antacid, Maalox Maalox was a brand of antacid owned by Sanofi.Their main product is a flavored liquid containing a suspension of aluminum hydroxide and magnesium hydroxide, which act to neutralize or reduce stomach acid, for the purpose of relieving the symptoms of indigestion, heartburn, gastroesophageal reflux disease, and also stomach or duodenal ulcers.
Keeping track of the latest product and food recalls can be a challenge, so Consumer Ally has collected them in one place for you to check each week. Here is the recall roundup from the past
The GI cocktail is a mixture of a viscous anesthetic, an antacid, and an anticholinergic. [1] [2] Common viscous anesthetics use are viscous lidocaine or xylocaine.Common antacids used are magnesium hydroxide, aluminum hydroxide, or simethicone (more commonly known as Mylanta or Maalox). [3]
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, [3] Kenvue is the proprietor of well-known brands such as Aveeno, [4] Band-Aid, [5] Benadryl, Combantrin, Zyrtec, [6] Johnson's, [7] Listerine, [8] Mylanta, Neutrogena, [4] Trosyd, Calpol, Tylenol, [8] and Visine.
Known as the "JV," this 50/50 joint venture between Johnson & Johnson and Merck handled the OTC product lines Pepcid, Mylanta, and Mylicon and is located at the McNeil Consumer Healthcare headquarters in Fort Washington, Pennsylvania. In September 2011, however, the JV ended, when Merck sold its 50 percent interest in the joint venture.
Drugs or medicines may be withdrawn from commercial markets because of risks to patients, but also because of commercial reasons (e.g. lack of demand and relatively high production costs).